About this Journal Submit a Manuscript Table of Contents
Journal of Nutrition and Metabolism
Volume 2012 (2012), Article ID 950517, 8 pages
http://dx.doi.org/10.1155/2012/950517
Research Article

Partial Replacement with Menhaden Oil Improves Peripheral Neuropathy in High-Fat-Fed Low-Dose Streptozotocin Type 2 Diabetic Rat

1Department of Internal Medicine, University of Iowa, Iowa City, IA 52246, USA
2Iowa City VA Health Care System, U.S. Department of Veterans Affairs, Iowa City, IA 52246, USA

Received 22 June 2012; Accepted 2 August 2012

Academic Editor: Cindy Davis

Copyright © 2012 Lawrence J. Coppey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. De Caterina, “Drug therapy: n-3 fatty acids in cardiovascular disease,” The New England Journal of Medicine, vol. 364, no. 25, pp. 2439–2450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, “Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease,” Circulation, vol. 106, no. 21, pp. 2747–2757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. Calder, “n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored,” Clinical Science, vol. 107, no. 1, pp. 1–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Siscovick, T. E. Raghunathan, I. King et al., “Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest,” Journal of the American Medical Association, vol. 274, no. 17, pp. 1363–1367, 1995. View at Scopus
  5. C. M. Albert, H. Campos, M. J. Stampfer et al., “Blood levels of long-chain n-3 fatty acids and the risk of sudden death,” The New England Journal of Medicine, vol. 346, no. 15, pp. 1113–1118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Gerbi, J. M. Maixent, J. L. Ansaldi et al., “Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats,” Journal of Nutrition, vol. 129, no. 1, pp. 207–213, 1999. View at Scopus
  7. S. Pitel, D. Raccah, A. Gerbi, G. Pieroni, P. Vague, and T. C. Coste, “At low doses, a γ-linolenic acid-lipoic acid conjugate is more effective than docosahexaenoic acid-enriched phospholipids in preventing neuropathy in diabetic rats,” Journal of Nutrition, vol. 137, no. 2, pp. 368–372, 2007. View at Scopus
  8. K. C. Dines, M. A. Cotter, and N. E. Cameron, “Contrasting effects of treatment with ω-3 and ω-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats,” Diabetologia, vol. 36, no. 11, pp. 1132–1138, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. K. C. Dines, N. E. Cameron, and M. A. Cotter, “Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 273, no. 1, pp. 49–55, 1995. View at Scopus
  10. N. E. Cameron and M. A. Cotter, “Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats,” Acta Diabetologica, vol. 31, no. 4, pp. 220–225, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gillam, A. Noto, P. Zahradka, and C. G. Taylor, “Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa Zucker rats,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 81, no. 5-6, pp. 331–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Podolin, E. C. Gayles, Y. Wei, J. S. Thresher, and M. J. Pagliassotti, “Menhaden oil prevents but does not reverse sucrose-induced insulin resistance in rats,” American Journal of Physiology, vol. 274, no. 3, pp. R840–R848, 1998. View at Scopus
  13. Y. Okuda, M. Mizutani, M. Ogawa et al., “Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus,” Journal of Diabetes and its Complications, vol. 10, no. 5, pp. 280–287, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Reed, K. Meszaros, L. J. Entes et al., “A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat,” Metabolism, vol. 49, no. 11, pp. 1390–1394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. E. P. Davidson, L. J. Coppey, A. Holmes, B. Dake, and M. A. Yorek, “Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications,” European Journal of Pharmacology, vol. 688, no. 3, pp. 497–506, 2011.
  17. C. L. Oltman, E. P. Davidson, L. J. Coppey, T. L. Kleinschmidt, D. D. Lund, and M. A. Yorek, “Attenuation of vascular/neural dysfunction in zucker rats treated with enalapril or rosuvastatin,” Obesity, vol. 16, no. 1, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. J. Coppey, E. P. Davidson, J. A. Dunlap, D. D. Lund, and M. A. Yorek, “Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve,” Experimental Diabesity Research, vol. 1, no. 2, pp. 131–143, 2000. View at Scopus
  19. I. G. Obrosova, F. Li, O. I. Abatan, et al., “Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy,” Diabetes, vol. 53, no. 3, pp. 711–720, 2004.
  20. K. K. Beiswenger, N. A. Calcutt, and A. P. Mizisin, “Epidermal nerve fiber quantification in the assessment of diabetic neuropathy,” Acta Histochemica, vol. 110, no. 5, pp. 351–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. P. Davidson, L. J. Coppey, N. A. Calcutt, C. L. Oltman, and M. A. Yorek, “Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 4, pp. 306–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. L. Oltman, L. J. Coppey, J. S. Gellett, E. P. Davidson, D. D. Lund, and M. A. Yorek, “Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats,” American Journal of Physiology, vol. 289, no. 1, pp. E113–E122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Yorek, D. K. Strom, and A. A. Spector, “Effect of membrane polyunsaturation on carrier-mediated transport in cultured retinoblastoma cells: alterations in taurine uptake,” Journal of Neurochemistry, vol. 42, no. 1, pp. 254–261, 1984. View at Scopus
  24. M. A. Yorek, R. R. Bohnker, D. T. Dudley, and A. A. Spector, “Comparative utilization of n-3 polyunsaturated fatty acids by cultured human Y-79 retinoblastoma cells,” Biochimica et Biophysica Acta, vol. 795, no. 2, pp. 277–285, 1984. View at Publisher · View at Google Scholar · View at Scopus
  25. N. S. Kalupahana, K. Claycombe, S. J. Newman et al., “Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation,” Journal of Nutrition, vol. 140, no. 11, pp. 1915–1922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. González-Périz, R. Horrillo, N. Ferré et al., “Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins,” FASEB Journal, vol. 23, no. 6, pp. 1946–1957, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. E. P. Davidson, L. J. Coppey, A. Holmes, and M. A. Yorek, “Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats,” European Journal of Pharmacology, vol. 677, no. 1–3, pp. 180–187, 2012.
  28. R. Valenzuela and L. A. Videla, “The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ration in development of non-alcoholic fatty liver associated with obesity,” Food Function, vol. 2, no. 11, pp. 644–648, 2011.
  29. N. Siriwardhana, N. S. Kalupahana, and N. Moustaid-Moussa, “Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid,” Advanced Food Nutrition Research, vol. 65, pp. 211–222, 2012.
  30. N. S. Kalupahana, K. J. Claycombe, and N. Moustaid-Moussa, “(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights,” Advanced Nutrition, vol. 2, no. 4, pp. 304–316, 2011.
  31. J. M. Tishinsky, R. A. Gulli, K. L. Mullen, D. J. Dyck, and L. E. Robinson, “Fish oil prevents high-saturated fat diet-induced impairments in adiponectin and insulin response in rodent soleus muscle,” American Journal of Regulatory Integrative and Comparative Physiology, vol. 302, no. 5, pp. R598–R605, 2012.
  32. N. Siriwardhana, N. S. Kalupahana, and N. Moustaid-Moussa, “Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid,” Advanced Food Nutrition Research, vol. 65, pp. 211–222, 2012.
  33. M. J. Moreno-Aliaga, S. Lorente-Cebrián, and J. A. Martínez, “Regulation of adipokine secretion by n-3 fatty acids,” Proceedings of the Nutrition Society, vol. 69, no. 3, pp. 324–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Takayama, K. Nakamoto, N. Totani et al., “Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis,” Journal of Oleo Science, vol. 59, no. 8, pp. 407–414, 2010. View at Scopus
  35. H. A. Marsman, M. Heger, J. J. Kloek et al., “Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by 1H-magnetic resonance spectroscopy in a rat model,” Journal of Gastroenterology and Hepatology, vol. 26, no. 2, pp. 356–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. C. D. Byrne, “Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management,” Diabetic Medicine, vol. 29, no. 7, 2012.
  37. G. S. Masterton, J. N. Plevris, and P. C. Hayes, “Review article: Omega-3 fatty acids—A promising novel therapy for non-alcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 7, pp. 679–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Ariel and C. N. Serhan, “Resolvins and protectins in the termination program of acute inflammation,” Trends in Immunology, vol. 28, no. 4, pp. 176–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Kohli and B. D. Levy, “Resolvins and protectins: Mediating solutions to inflammation,” British Journal of Pharmacology, vol. 158, no. 4, pp. 960–971, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. S. Cortina, J. He, N. Li, N. G. Bazan, and H. E. P. Bazan, “Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA,” Investigative Ophthalmology and Visual Science, vol. 51, no. 2, pp. 804–810, 2010. View at Publisher · View at Google Scholar · View at Scopus